« Back
Home /
SLC27A5 Antibody (Center) Blocking Peptide

SLC27A5 Antibody (Center) Blocking Peptide

Item no.	ABC-BP9015c
Manufacturer	Abcepta
Amount	500 ug
Category	Metabolism Glucose Homeostasis Cholesterol & Lipid Metabolism Peptides & Proteins Obesity Lipid & Fatty Acid Transport Peptides
Type	Peptides
Format	Lyophilized
Specific against	other
Citations	Watkins,P.A., et.al., Prostaglandins Leukot. Essent. Fatty Acids 60 (5-6), 323-328 (1999)Steinberg,S.J., et.al., J. Biol. Chem. 275 (21), 15605-15608 (2000)
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	Bile acyl-CoA synthetase,BACS,Bile acid-CoA ligase,BA-CoA ligase,BAL,Cholate--CoA ligase,Fatty acid transport protein 5,FATP-5,Fatty-acid-coenzyme A ligase,very long-chain 3,Solute carrier family 27 member 5,Very long-chain acyl-CoA synthetase homolog 2,VLCS-H2,VLCSH2,Very long-chain acyl-CoA synthetase-related protein,VLACS-related,VLACSR,SLC27A5,ACSB,ACSVL6,FACVL3,FATP5
Similar products	BAL, SLC27A5, ACSB, ACSVL6, FACVL3, FATP5, VLACSR, VLCS-H2, VLCSH2, very long-chain 3, Fatty-acid-coenzyme A ligase, Bile acyl-CoA synthetase, BACS, Bile acid-CoA ligase, BA-CoA ligase, Cholate--CoA ligase, Fatty acid transport protein 5, FATP-5, Solute carrier family 27 member 5, Very long-chain acyl-CoA synthetase homolog 2, Very long-chain acyl-CoA synthetase-related protein, VLACS-related
Available
Manufacturer - Category	Peptides; Blocking Peptides
Manufacturer - Targets	The synthetic peptide sequence used to generate the antibody AP9015c was selected from the Center region of human SLC27A5. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Bio Background	SLC27A5 is an isozyme of very long-chain acyl-CoA synthetase (VLCS). It is capable of activating very long-chain fatty-acids containing 24- and 26-carbons. It is expressed in liver and associated with endoplasmic reticulum but not with peroxisomes. Its primary role is in fatty acid elongation or complex lipid synthesis rather than in degradation.
Gene Name	SLC27A5
Subtitle	Synthetic peptide
Formulation	Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

ABC-BP9015c-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 500 ug

available

Delivery expected until 11/6/2025

Express Delivery: Save 14 days

Compare

Add to wishlist

Get an offer